Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases

C Vargas, R De Abreu Lourenco, M Espinoza… - … Health Economics and …, 2024 - Springer
Objective This article reviews the assessment pathways that have been implemented
worldwide to facilitate access to drugs for patients with rare diseases. Methods The …

Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries

M Kamusheva, M Manova, AT Savova… - Frontiers in …, 2018 - frontiersin.org
Objectives: The aim of the study was to compare the access of patients with rare diseases
(RDs) to biotechnological drugs in several Central and Eastern European countries …

Rare disease patients' needs: an up-to-date analysis and future directions.

M Kamusheva, P Milushewa - Pharmacia, 2021 - go.gale.com
The interest to rare diseases has increased in the recent decades. Legislation seeks to
facilitate patients' access to innovative and effective treatment and to define incentives for …

An overview of the reimbursement decision-making processes in Bulgaria as a reference country for the middle-income European countries

M Kamusheva, M Vassileva, A Savova… - Frontiers in Public …, 2018 - frontiersin.org
Background Policy makers face a lot of challenges in the process of drug reimbursement
decision-making, especially in the context of entering the market of more and more …

Pharmacotherapeutic patterns and patients' access to pharmacotherapy for some rare diseases in Bulgaria–a pilot comparative study

M Kamusheva, M Dimitrova, K Tachkov… - Frontiers in …, 2021 - frontiersin.org
Provision of the latest innovative and advanced therapies for rare diseases (RDs) patients,
following the international therapeutic recommendations, is crucial and necessary for both …

[PDF][PDF] Commodity analysis of medical products used in adult incontinence

T Diadiun, I Baranova, S Musozoda, D Semeniv… - …, 2021 - pharmacia.pensoft.net
There are problems people don't want to talk about, and one of them is incontinence in
adults. This is a fairly common and delicate problem. It negatively affects human life. This …

[PDF][PDF] Rare disease patients' needs: an up-to-date analysis and future directions. Pharmacia 68 (4): 763–770

M Kamusheva, P Milushewa - 2021 - pharmacia.pensoft.net
The interest to rare diseases has increased in the recent decades. Legislation seeks to
facilitate patients' access to innovative and effective treatment and to define incentives for …

Clinical and economic assessment of nusinersen: the bulgarian perspective

MS Kamusheva, MJ Dimitrova - Expert Opinion on Orphan Drugs, 2020 - Taylor & Francis
Introduction Spinal muscular atrophy (SMA) is a very serious debilitating rare condition
mainly affecting newborns and infants. Areas covered The aim of current chapter is to …

[PDF][PDF] Науково-методичні підходи до удосконалення фармацевтичного забезпечення хворих на легеневу гіпертензію

ІС Даценко - 2023 - ir.nuozu.edu.ua
Untitled Page 1 Page 2 2 АНОТАЦІЯ Даценко ІСНауково-методичні підходи до
удосконалення фармацевтичного забезпечення хворих на легеневу гіпертензію …

[PDF][PDF] Организация оказания фармацевтической помощи больным орфанными заболеваниями в системе государственных социальных гарантий

ФЗ Талбауи - 2023 - dspace.nuph.edu.ua
0 АННОТАЦИЯ Проанализированы современные подходы к организации оказания
фармацевтической помощи больным орфанным заболеваниям в системе …